ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Latest Anti-TRT hype before study results are even released
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Re-Ride" data-source="post: 33129" data-attributes="member: 8395"><p>Touted as the "latest in the medical saga that started 15 years ago when testosterone which for decades had been used mainly in rare clinical circumstances, increasingly is prescribed for middle-aged and older men whose testosterone levels decline" MedPageToday "reports" <a href="http://www.medpagetoday.com/Endocrinology/GeneralEndocrinology/56255" target="_blank">http://www.medpagetoday.com/Endocrinology/GeneralEndocrinology/56255</a></p><p></p><p>The specter of TRT-related cardiovascular disease, blood clots and prostate cancer are once again raised.</p><p></p><p>Preliminary study results addressing thus far only the benefits libido and "vitality" among elderly obese white men are published here: <a href="http://www.nejm.org/doi/full/10.1056/NEJMoa1506119" target="_blank">http://www.nejm.org/doi/full/10.1056/NEJMoa1506119</a></p><p></p><p>The study participants were elderly obese symptomatic white men averaging 72 years included no one younger than 65. Only subjective benefits of "vitality" and only using Androgel for 12 months are reviewed at this point.. </p><p></p><p>"Four more arms of the trial (cognitive function, anemia, bone density, and cardiovascular health) won't likely be published until late 2016 or 2017"</p><p></p><p>The rush to judgement:</p><p></p><p>"it does not make me feel comfortable recommending this medication for routine use in otherwise healthy men," "I would not be inclined to prescribe this medication."</p><p><a href="http://www.uwhealth.org/findadoctor/profile/james-h-stein-md/7618" target="_blank">James Stein, MD</a>, professor of cardiovascular medicine, University of Wisconsin School of Medicine and Public Health</p><p></p><p>"Concerns about increased risk of prostate cancer, blood clots, and cardiovascular problems have been raised about testosterone"</p><p>""Millions of men take testosterone, hoping for a fountain of youth," </p><p> "This therapy is too risky for widespread use"</p><p><a href="http://my.clevelandclinic.org/staff_directory/staff_display?doctorid=1185" target="_blank">Steven Nissen, MD</a>, chairman of cardiovascular medicine, Cleveland Clinic Foundation.</p><p></p><p>"Therapy was not a panacea and the findings alone might be insufficient to support a decision to initiate testosterone therapy in symptomatic older men," wrote <a href="https://www.ohsu.edu/xd/health/services/providers/index.cfm?personID=586" target="_blank">Eric Orwoll, MD</a>, physician, Oregon Health and Science University.</p></blockquote><p></p>
[QUOTE="Re-Ride, post: 33129, member: 8395"] Touted as the "latest in the medical saga that started 15 years ago when testosterone which for decades had been used mainly in rare clinical circumstances, increasingly is prescribed for middle-aged and older men whose testosterone levels decline" MedPageToday "reports" [url]http://www.medpagetoday.com/Endocrinology/GeneralEndocrinology/56255[/url] The specter of TRT-related cardiovascular disease, blood clots and prostate cancer are once again raised. Preliminary study results addressing thus far only the benefits libido and "vitality" among elderly obese white men are published here: [url]http://www.nejm.org/doi/full/10.1056/NEJMoa1506119[/url] The study participants were elderly obese symptomatic white men averaging 72 years included no one younger than 65. Only subjective benefits of "vitality" and only using Androgel for 12 months are reviewed at this point.. "Four more arms of the trial (cognitive function, anemia, bone density, and cardiovascular health) won't likely be published until late 2016 or 2017" The rush to judgement: "it does not make me feel comfortable recommending this medication for routine use in otherwise healthy men," "I would not be inclined to prescribe this medication." [URL="http://www.uwhealth.org/findadoctor/profile/james-h-stein-md/7618"]James Stein, MD[/URL], professor of cardiovascular medicine, University of Wisconsin School of Medicine and Public Health "Concerns about increased risk of prostate cancer, blood clots, and cardiovascular problems have been raised about testosterone" ""Millions of men take testosterone, hoping for a fountain of youth," "This therapy is too risky for widespread use" [URL="http://my.clevelandclinic.org/staff_directory/staff_display?doctorid=1185"]Steven Nissen, MD[/URL], chairman of cardiovascular medicine, Cleveland Clinic Foundation. "Therapy was not a panacea and the findings alone might be insufficient to support a decision to initiate testosterone therapy in symptomatic older men," wrote [URL="https://www.ohsu.edu/xd/health/services/providers/index.cfm?personID=586"]Eric Orwoll, MD[/URL], physician, Oregon Health and Science University. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Latest Anti-TRT hype before study results are even released
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top